120 related articles for article (PubMed ID: 36515343)
1. RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK.
Tabaeian SP; Mahmoudi T; Rezamand G; Nobakht H; Dabiri R; Farahani H; Asadi A; Zali MR
Arq Gastroenterol; 2022; 59(4):483-487. PubMed ID: 36515343
[TBL] [Abstract][Full Text] [Related]
2. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
3. Association of resistin (rs3745367) and urotensin II (rs228648 and rs2890565) gene polymorphisms with risk of type 2 diabetes mellitus in Indian population.
Kumar V; Singh J; Bala K; Singh J
Mol Biol Rep; 2020 Dec; 47(12):9489-9497. PubMed ID: 33269434
[TBL] [Abstract][Full Text] [Related]
4. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.
Dabiri R; Mahmoudi T; Sabzikarian M; Asadi A; Farahani H; Nobakht H; Maleki I; Mansour-Ghanaei F; Derakshshan F; Zali MR
Acta Gastroenterol Belg; 2020; 83(2):271-276. PubMed ID: 32603046
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease.
Mahmoudi T; Nouri S; Zarei F; Najafabadi ZN; Sanei M; Sayedsalehi S; Rezamand G; Asadi A; Dabiri R; Nobakht H; Farahani H; Tabaeian SP; Zali MR
Arch Endocrinol Metab; 2023 Nov; 68():e230017. PubMed ID: 37948568
[TBL] [Abstract][Full Text] [Related]
6. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.
Nobakht H; Mahmoudi T; Sabzikarian M; Tabaeian SP; Rezamand G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Maleki I; Zali MR
Arq Gastroenterol; 2020; 57(2):203-208. PubMed ID: 33206859
[TBL] [Abstract][Full Text] [Related]
7. Interaction of Polymorphisms of Resistin Gene Promoter -420C/G, Glutathione Peroxidase -1 Gene Pro198Leu and Cigarette Smoking in Nonalcoholic Fatty Liver Disease.
Zhang CX; Guo LK; Qin YM; Li GY
Chin Med J (Engl); 2015 Sep; 128(18):2467-73. PubMed ID: 26365964
[TBL] [Abstract][Full Text] [Related]
8. Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study.
Nobakht H; Mahmoudi T; Rezamand G; Tabaeian SP; Jeddi G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Kaboli SA; Derakhshan F; Zali MR
Lab Med; 2022 Sep; 53(5):504-508. PubMed ID: 35713614
[TBL] [Abstract][Full Text] [Related]
9. The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.
Rezamand G; Mahmoudi T; Tabaeian SP; Farahani H; Shahinmehr F; Nobakht H; Dabiri R; Asadi A; Mansour-Ghanaei F; Zali MR
Physiol Int; 2021 Sep; 108(3):342-352. PubMed ID: 34529585
[TBL] [Abstract][Full Text] [Related]
10. The Relevance of Single-nucleotide Polymorphism +62 G>A to the Expression of Resistin Gene Affecting Serum Resistin Levels in Metabolic Syndrome in the Egyptian Population.
Ibrahim SM; Bastawy AA
Curr Pharm Biotechnol; 2020; 21(7):626-634. PubMed ID: 31820685
[TBL] [Abstract][Full Text] [Related]
11. Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients.
El-Shal AS; Pasha HF; Rashad NM
Gene; 2013 Feb; 515(1):233-8. PubMed ID: 23178185
[TBL] [Abstract][Full Text] [Related]
12. Association of -394C>G and -420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese.
Chi S; Lan C; Zhang S; Liu H; Wang X; Chen Y; Chen X; Chen S; Zhang W
Mol Cell Biochem; 2009 Oct; 330(1-2):31-8. PubMed ID: 19381781
[TBL] [Abstract][Full Text] [Related]
13. Association of RETN C-420G single nucleotide polymorphism with type 2 diabetes mellitus in Pakistani Punjabi Rajput population.
Nadeem A; Mumtaz S; Saif MW; Naveed AK; Aslam M; Mansoor Q; Siddiqui A; Ismail M
J Pak Med Assoc; 2018 Nov; 68(11):1584-1589. PubMed ID: 30410133
[TBL] [Abstract][Full Text] [Related]
14. Resistin gene polymorphisms are associated with acne and serum lipid levels, providing a potential nexus between lipid metabolism and inflammation.
Younis S; Blumenberg M; Javed Q
Arch Dermatol Res; 2016 May; 308(4):229-37. PubMed ID: 26858108
[TBL] [Abstract][Full Text] [Related]
15. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism.
Musso G; Bo S; Cassader M; De Michieli F; Gambino R
Am J Clin Nutr; 2013 Oct; 98(4):895-906. PubMed ID: 23985808
[TBL] [Abstract][Full Text] [Related]
16. Common quantitative trait locus downstream of RETN gene identified by genome-wide association study is associated with risk of type 2 diabetes mellitus in Han Chinese: a Mendelian randomization effect.
Chung CM; Lin TH; Chen JW; Leu HB; Yin WH; Ho HY; Sheu SH; Tsai WC; Chen JH; Lin SJ; Pan WH
Diabetes Metab Res Rev; 2014 Mar; 30(3):232-40. PubMed ID: 24123702
[TBL] [Abstract][Full Text] [Related]
17. The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease.
Tabaeian SP; Mahmoudi T; Sabzikarian M; Rezamand G; Dabiri R; Nobakht H; Asadi A; Farahani H; Mansour-Ghanaei F; Zali MR
J Gastrointestin Liver Dis; 2021 Jun; 30(2):233-239. PubMed ID: 34174062
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
Musso G; Saba F; Cassader M; Paschetta E; De Michieli F; Pinach S; Framarin L; Berrutti M; Leone N; Parente R; Ayoubi Khajekini MT; Zarovska A; Gambino R
Am J Gastroenterol; 2019 Apr; 114(4):607-619. PubMed ID: 30920415
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease.
Nouri S; Mahmoudi T; Hojjati F; Najafabadi ZN; Shafiee R; Sayedsalehi S; Dehghanitafti A; Ardalani A; Kohansal K; Rezamand G; Asadi A; Nobakht H; Dabiri R; Farahani H; Tabaeian SP; Zali MR
Lab Med; 2024 Mar; 55(2):215-219. PubMed ID: 37481466
[TBL] [Abstract][Full Text] [Related]
20. Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China.
Chen LZ; Ding HY; Liu SS; Liu Q; Jiang XJ; Xin YN; Xuan SY
Lipids Health Dis; 2019 Feb; 18(1):45. PubMed ID: 30738435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
